These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 21432574

  • 21. What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD).
    Advokat C.
    Neurosci Biobehav Rev; 2010 Jul; 34(8):1256-66. PubMed ID: 20381522
    [Abstract] [Full Text] [Related]

  • 22. Instability of the DSM-IV Subtypes of ADHD from preschool through elementary school.
    Lahey BB, Pelham WE, Loney J, Lee SS, Willcutt E.
    Arch Gen Psychiatry; 2005 Aug; 62(8):896-902. PubMed ID: 16061767
    [Abstract] [Full Text] [Related]

  • 23. Differentiation of attention-deficit/hyperactivity disorder subtypes: application of a neuropsychological model of attention.
    Lockwood KA, Marcotte AC, Stern C.
    J Clin Exp Neuropsychol; 2001 Jun; 23(3):317-30. PubMed ID: 11404810
    [Abstract] [Full Text] [Related]

  • 24. Distinct response time distributions in attention deficit hyperactivity disorder subtypes.
    Querne L, Berquin P.
    J Atten Disord; 2009 Jul; 13(1):66-77. PubMed ID: 18725655
    [Abstract] [Full Text] [Related]

  • 25. Digit Span components as predictors of attention problems and executive functioning in children.
    Rosenthal EN, Riccio CA, Gsanger KM, Jarratt KP.
    Arch Clin Neuropsychol; 2006 Feb; 21(2):131-9. PubMed ID: 16198530
    [Abstract] [Full Text] [Related]

  • 26. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 27. Snoring, sleep quality, and sleepiness across attention-deficit/hyperactivity disorder subtypes.
    LeBourgeois MK, Avis K, Mixon M, Olmi J, Harsh J.
    Sleep; 2004 May 01; 27(3):520-5. PubMed ID: 15164909
    [Abstract] [Full Text] [Related]

  • 28. Neuropsychological executive functions and DSM-IV ADHD subtypes.
    Nigg JT, Blaskey LG, Huang-Pollock CL, Rappley MD.
    J Am Acad Child Adolesc Psychiatry; 2002 Jan 01; 41(1):59-66. PubMed ID: 11800208
    [Abstract] [Full Text] [Related]

  • 29. Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder.
    Kantak KM, Singh T, Kerstetter KA, Dembro KA, Mutebi MM, Harvey RC, Deschepper CF, Dwoskin LP.
    Behav Neurosci; 2008 Apr 01; 122(2):340-57. PubMed ID: 18410173
    [Abstract] [Full Text] [Related]

  • 30. Normal attention orienting but abnormal stimulus alerting and conflict effect in combined subtype of ADHD.
    Oberlin BG, Alford JL, Marrocco RT.
    Behav Brain Res; 2005 Nov 30; 165(1):1-11. PubMed ID: 16213034
    [Abstract] [Full Text] [Related]

  • 31. ADHD subtypes: do they differ in their executive functioning profile?
    Geurts HM, Verté S, Oosterlaan J, Roeyers H, Sergeant JA.
    Arch Clin Neuropsychol; 2005 Jun 30; 20(4):457-77. PubMed ID: 15896560
    [Abstract] [Full Text] [Related]

  • 32. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
    Escobar R, Hervas A, Soutullo C, Mardomingo MJ, Uruñuela A, Gilaberte I.
    Actas Esp Psiquiatr; 2008 Jun 30; 36(5):285-94. PubMed ID: 18830848
    [Abstract] [Full Text] [Related]

  • 33. [Cognitive aspects of attention deficit hyperactivity disorder in children].
    Cupello S.
    Rev Prat; 2002 Nov 15; 52(18):2005-8. PubMed ID: 12602166
    [Abstract] [Full Text] [Related]

  • 34. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder.
    Pliszka SR.
    Child Adolesc Psychiatr Clin N Am; 2000 Jul 15; 9(3):525-40, vii. PubMed ID: 10944655
    [Abstract] [Full Text] [Related]

  • 35. [Attention-deficit/hyperactivity disorder. Clinical and treatment aspects].
    Diaconu G, Grigore I, Burlea M.
    Rev Med Chir Soc Med Nat Iasi; 2009 Jul 15; 113(3):656-62. PubMed ID: 20191811
    [Abstract] [Full Text] [Related]

  • 36. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A, Richard C, Prinzo R, Binder C.
    Curr Med Res Opin; 2006 Dec 15; 22(12):2557-66. PubMed ID: 17166338
    [Abstract] [Full Text] [Related]

  • 37. Age and medication effects on rhythmic responses in ADHD: possible oscillatory mechanisms?
    Ben-Pazi H, Shalev RS, Gross-Tsur V, Bergman H.
    Neuropsychologia; 2006 Dec 15; 44(3):412-6. PubMed ID: 16083921
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 15; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 39. Performance monitoring and response inhibition in anxiety disorders with and without comorbid ADHD.
    Korenblum CB, Chen SX, Manassis K, Schachar RJ.
    Depress Anxiety; 2007 Feb 15; 24(4):227-32. PubMed ID: 17004236
    [Abstract] [Full Text] [Related]

  • 40. [The effects of psychostimulants on the cognitive results and behaviour of children with the combined subtype of attention deficit with hyperactivity].
    Mulas F, Roselló B, Morant A, Hernández S, Pitarch I.
    Rev Neurol; 2007 Feb 15; 35(1):17-24. PubMed ID: 12389187
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.